MDRNA, Inc.
(NASDAQ:MRNA)|
0.24 -0.05 (-17.24%) Dec 04 - Close |
|
|
|
After-Hours 0.24 0.00 (0.00%) Thu, 4 Dec 2008 7:40 PM
- Compare MRNA with:
- View: Line | Candlestick
Company Profile
MDRNA, Inc.
3830 Monte Villa Parkway
Bothell, WA 98021
United States - Map
Phone: (425) 908-3600
Fax: (425) 908-3650
Website: www.nastech.com
State of incorporation: Delaware
CEO: J. Michael French
Employees: 157
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Develops intranasal drug delivery technology
The Company's business is in the development of RNA-based technologies including RNA interference and microRNA.
Recent news for MRNA
-
MDRNA Reports UNA-Modified siRNAs Effectively Silence Gene Targets in Animal Models
Marketwire - Yesterday at 8:00 ET
-
MDRNA gets NASDAQ warning letter
bizjournals.com - Nov 26 at 7:05 ET
-
MDRNA, Inc. to Present at Piper Jaffray Healthcare Conference
Marketwire - Nov 25 at 8:00 ET
-
EDGAR Online - Nov 24 at 4:05 ET
-
MDRNA, Inc. Receives NASDAQ Notification
Marketwire - Nov 24 at 4:01 ET
-
EDGAR Online Financials - Nov 20 at 9:04 ET
-
New Star Analyst Rankings for MDRNA INC
StarMine - Nov 16 at 9:33 ET
-
New Star Analyst Rankings for MDRNA INC
StarMine - Nov 14 at 9:23 ET
-
MDRNA, Inc. Earnings Call scheduled for 4:30 pm ET today
CCBN - Nov 13 at 4:30 ET
-
EDGAR Online - Nov 13 at 4:06 ET
